Stage C Heart Failure (NYHA Class I)
Clinical Profile: Elevated filling pressures with mild symptoms
Recommended Approach:
- Initiate GDMT without delay:
- SGLT2 inhibitor
- ARNI (preferred) or ACEi/ARB
- Mineralocorticoid receptor antagonist (MRA)
- Reinforce lifestyle modification
Care Support:
- Refer to pharmacy or disease management programs
- Address hypertension, CKD, obesity, and physical activity
Follow-Up Strategy:
- Optimize GDMT to target doses within 3–6 months
- Reassess annually or with symptom changes
Additional Considerations:
- Selective echocardiography based on clinical suspicion
- Consider cardiology referral if symptoms progress